⌘K

Login Start Free

Home/Filings/4/0001104659-19-032142

4//SEC Filing

MUELLER PETER 4

Accession 0001104659-19-032142

CIK 0001720893other

View on SEC.gov Company Profile

Filed

May 27, 8:00 PM ET

Accepted

May 28, 9:00 PM ET

Size

14.8 KB

Accession

0001104659-19-032142

Insider Transaction Report

Form 4

Period: 2019-05-23

BioXcel Therapeutics, Inc.BTAI

Director

Transactions

Award
Stock Option (Right to Buy)
2019-05-23+14,700→ 14,700 total
Exercise: $10.04Exp: 2029-05-23→ Common Stock (14,700 underlying)

Footnotes (1)

[F1]The option will vest in full and become exercisable on the first anniversary of the grant date.

Documents

2 files

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother

Related Parties

1

filerCIK 0001256126

Filing Metadata

Form type: 4
Filed: May 27, 8:00 PM ET
Accepted: May 28, 9:00 PM ET
Size: 14.8 KB

View on SEC.gov